Pharm marketing
Follow
Find
737 views | +0 today
Your new post is loading...
Your new post is loading...
Scooped by Muriel Gosnat
Scoop.it!

CSL Behring enrolls first patient in COMPACT study - Pharmaceutical Business Review

CSL Behring announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

BioMarin gets positive opinion from EMA's CHMP for Morquio A Syndrome drug Vimizim - Pharmaceutical Business Review

US-based BioMarin Pharmaceutical has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has is
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Vertex gets FDA approval for Kalydeco sNDA - Pharmaceutical Business Review

US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Ap
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Sprout Pharmaceuticals receives clear guidance from FDA on path forward to resubmit NDA for flibanserin - Pharmaceutical Business Review

Sprout Pharmaceuticals has announced that its Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the FDA on
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Isis gets positive opinion on European orphan drug status for ISIS-TTR Rx - Pharmaceutical Business Review

US-based Isis Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending ISIS-T
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Bayer starts new Phase III rivaroxaban trial - Pharmaceutical Business Review

Bayer HealthCare has initiated a Phase III clinical trial 'EINSTEIN CHOICE' to evaluate two doses of its once-daily novel oral anticoagulant rivaroxab
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Aveo, Astellas end deal to develop cancer drug tivozanib - Pharmaceutical Business Review

Aveo, Astellas end deal to develop cancer drug tivozanib - Pharmaceutical Business Review | Pharm marketing | Scoop.it
AVEO Oncology and Astellas Pharma have agreed to end their worldwide collaboration and license agreement for the development and commercialization of
more...
No comment yet.
Rescooped by Muriel Gosnat from Le monde du mobile et ses nouveaux usages : news web mobile, apps en m sante et telemedecine, m learning , e marketing , etc
Scoop.it!

Un des futurs possibles pour les objets connectés

Un des futurs possibles pour les objets connectés | Pharm marketing | Scoop.it

Comme la majorité des nouveautés technologiques ayant émergés ces dernières années, les objets connectés "à porter", que les anglophones désignent sous le (Un des futurs possibles pour les objets connectés "à porter" ?


Via Nicolas Prigent, Lionel Reichardt / le Pharmageek, dbtmobile
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

CEL-SCI to commence Phase III clinical trial of Multikine in head and neck cancer - Pharmaceutical Business Review

CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Medac gets FDA acceptance of new drug application for MPI-2505 - Pharmaceutical Business Review

US-based Medac Pharma has reported the US Food and Drug Administration (FDA) acceptance of a new drug application (NDA) for its lead product candidate
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

California Stem Cell submits Phase II study protocol to FDA for ovarian cancer treatment - Pharmaceutical Business Review

California Stem Cell has submitted a Phase II protocol to the US Food and Drug Administration (FDA) for a double-blind study to assess its patient-spe
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

California Stem Cell submits Phase II study protocol to FDA for ovarian cancer treatment - Pharmaceutical Business Review

California Stem Cell has submitted a Phase II protocol to the US Food and Drug Administration (FDA) for a double-blind study to assess its patient-spe
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

FDA grants fast track designation to BioAlliance's cancer drug Validive - Pharmaceutical Business Review

BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Pluristem files orphan drug application to US FDA for preeclampsia - Pharmaceutical Business Review

Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLace
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Shire files Elvanse for an adult licence in UK, Denmark and Sweden - Pharmaceutical Business Review

The UK Medicines Healthcare products Regulatory Agency (MHRA) has accepted Shire's application for review of an adult indication, of its once-daily At
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Novartis releases positive results of Phase II trial of BCC drug sonidegib - Pharmaceutical Business Review

Novartis releases positive results of Phase II trial of BCC drug sonidegib - Pharmaceutical Business Review | Pharm marketing | Scoop.it
Swiss multinational pharmaceutical firm Novartis has released positive results of its Phase II trial of the investigational oral compound LDE225 (soni
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Otsuka- Lundbeck's schizophrenia drug Abilify Maintena gets Health Canada clearance - Pharmaceutical Business Review

Otsuka and Lundbeck has received approval from Health Canada to use its intramuscular (IM) once-monthly injectable formulation 'Abilify Maintena' for
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

California Stem Cell announces FDA approval of Phase II cancer stem cell clinical trial for ovarian cancer - Pharmaceutical Business Review

California Stem Cell has announced that the US Food and Drug Administration (FDA) has approved the company’s application to begin a Phase II clinical
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Prana releases positive results of Phase II Huntington disease trial - Pharmaceutical Business Review

Australian firm Prana Biotechnology has reported results of its Reach2HD Phase II clinical trial investigating PBT2 as a treatment for Huntington dise
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Galapagos completes enrollment in Phase II trial of GLPG0974 to treat ulcerative colitis - Pharmaceutical Business Review

Galapagos has completed patient enrollment in a clinical Proof of Concept Phase II trial of GLPG0974, for the treatment of ulcerative colitis, a debil
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

CHMP adopts positive opinion for FINOX Biotech's BEMFOLA to treat infertility - Pharmaceutical Business Review

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketin
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Oncology drives Roche profits | Pharmafile

Oncology drives Roche profits | Pharmafile | Pharm marketing | Scoop.it
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Pfizer releases results of two Phase III trials of NSCLC drug dacomitinib - Pharmaceutical Business Review

US-based pharmaceutical firm Pfizer has released top-line results from two randomized Phase III studies of the irreversible pan-HER kinase inhibitor d
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Kyowa Hakko Kirin launches long-acting erythropoiesis-stimulating agent in Japan - Pharmaceutical Business Review

Japanese pharmaceutical company Kyowa Hakko Kirin has announced the launch of its NESP injection 5μg plastic syringe as an additional formulation.
more...
No comment yet.
Scooped by Muriel Gosnat
Scoop.it!

Marina Biotech receives Japanese patent for DiLA2 nucleic acid delivery technology - Pharmaceutical Business Review

Marina Biotech, a biotechnology company, has received a patent notice from the Japan Patent Office covering its Di-alkylated Amino Acid (DiLA2) liposo
more...
No comment yet.